R&D | December 08, 2025
B Braun unveils ready-to-use antibiotic system
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
The PCR-based test, delivered via Roche’s cobas liat system, allows results to be obtained during a patient consultation in GP practices and Emergency Rooms
Here's a development that aims to keep your blood pressure in check. Literally!
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
Now a test that offers new precision in prostate cancer detection
Fresh Phase 1b/2a data highlight the strength of the iberdomide + daratumumab + dexamethasone combination in transplant-deferred or ineligible NDMM
Subscribe To Our Newsletter & Stay Updated
